TapImmune Inc. (OTCMKTS:TPIV) Regaining Lost Value

[[tagnumber 0]][[tagnumber 1]]TapImmune Inc. (OTCMKTS:TPIV)’s stock has been quite unpredictable and is seen embarking on long upward climbs followed by discouraging downward slides. We saw the ticker go up the charts on increased volumes in the beginning of April, but it quickly came crashing down, obliterating all the gains it had made.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]There were hopes that the filing of the company’s financial report for the fiscal 2015 would help the ticker, but it managed to do absolutely nothing for the price of [[tagnumber 6]]TPIV.[[tagnumber 7]] Here are some of the contents of the balance sheet that the company had on December 31, 2015.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 11]] [[tagnumber 12]]cash: $6.57 million[[tagnumber 13]] [[tagnumber 12]]current assets: $6.64 million[[tagnumber 13]] [[tagnumber 12]]current liabilities: $28 million[[tagnumber 13]] [[tagnumber 12]]revenues: ZERO[[tagnumber 13]] [[tagnumber 12]]annual net loss: $34.06 million[[tagnumber 13]] [[tagnumber 22]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]Those numbers weren’t exactly exciting, but [[tagnumber 6]]TPIV[[tagnumber 7]] is still one of very few OTC pharmaceutical companies that have great achievements and decent cash on hand in order to continue with its operations in the near future.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]As the company was slipping down the charts we saw some optimistic press releases coming from [[tagnumber 6]]TPIV[[tagnumber 7]] HQ. They managed to provide another upward run for the company stock in the end of last month. May also started rather well and we saw TPIV gain 11.72% in value yesterday, closing at $0.715 per share.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]Unfortunately, it seems that this is as high as [[tagnumber 6]]TPIV[[tagnumber 7]] can get at the moment. After gapping up at 73 cents per share in today’s session we see that the ticker is 4.20% down as of the writing of this article.[[tagnumber 2]]

You may also like...